Anebulo Pharmaceuticals
(NASDAQ:ANEB)
$2.80
0.0056[0.20%]
At close: Mar 19
$2.80
0[0.00%]
After Hours: 8:35AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Anebulo Pharmaceuticals Stock (NASDAQ:ANEB), Quotes and News Summary

Anebulo Pharmaceuticals Stock (NASDAQ: ANEB) stock price, news, charts, stock research, profile.

Open$2.704
Close$2.704
Volume / Avg.387.000 / 5.808K
Day Range2.704 - 2.704
52 Wk Range1.620 - 4.050
Market Cap$72.613M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
0.45%
Days to Cover4.58

Recent News

Substance Use Disorder Company Narrows Q2 Net Loss, Reports Progress On Cannabinoid Intoxication Drug
Substance use disorder-focused biopharmaceutical company Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported on Tuesday second quarter financial results for the three months ended Dec. 31, 2023, The company's primary focus is on developing therapy for acute cannabinoid intoxication (ACI).Total operating expenses in the second quarter of fiscal 2024 were $2.8 million compared with $3.8 million in the same period in fiscal 2023.Net loss in the second quarter of fiscal 2024 was $2.7 million, or $(0.11) per share, compared with a net loss of $3.8 million, or $(0.15) per share, in the second quarter of fiscal 2023.
Jelena Martinovic
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Lisa Levin
Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst Says
H.C.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About Anebulo Pharmaceuticals Inc
Sector
Health Care
Industry
Pharmaceuticals
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel soluti...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ANEB
SCYX

FAQ

Q

How do I buy Anebulo Pharmaceuticals (ANEB) stock?

A

You can purchase shares of Anebulo Pharmaceuticals (NASDAQ: ANEB) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Anebulo Pharmaceuticals's (ANEB) competitors?

A

Other companies in Anebulo Pharmaceuticals’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP) and Marinus Pharma (NASDAQ:MRNS).

Q

What is the target price for Anebulo Pharmaceuticals (ANEB) stock?

A

The latest price target for Anebulo Pharmaceuticals (NASDAQ: ANEB) was reported by Benchmark on Tuesday, October 3, 2023. The analyst firm set a price target for 8.00 expecting ANEB to rise to within 12 months (a possible 185.71% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Anebulo Pharmaceuticals (ANEB)?

A

The stock price for Anebulo Pharmaceuticals (NASDAQ: ANEB) is $2.8 last updated March 19, 2024 at 8:35 AM EDT.

Q

Does Anebulo Pharmaceuticals (ANEB) pay a dividend?

A

There are no upcoming dividends for Anebulo Pharmaceuticals.

Q

When is Anebulo Pharmaceuticals (NASDAQ:ANEB) reporting earnings?

A

Anebulo Pharmaceuticals’s Q3 earnings are confirmed for Thursday, May 9, 2024.

Q

Is Anebulo Pharmaceuticals (ANEB) going to split?

A

There is no upcoming split for Anebulo Pharmaceuticals.

Q

What sector and industry does Anebulo Pharmaceuticals (ANEB) operate in?

A

Anebulo Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch